<DOC>
	<DOCNO>NCT00384306</DOCNO>
	<brief_summary>The aim study establish association blood urine marker bone metabolism histomorphometric change ( change actual bone structure ) result short term oral prednisolone treatment patient COPD ( chronic obstructive pulmonary disease ) .</brief_summary>
	<brief_title>Effects Of Oral Prednisolone On Bone Metabolism In Patients With Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Inclusion criterion : Females subject must unable child . BMI 19 29.9 Nonsmokers , exsmokers current light smoker ( &lt; 10 cigarettes/day ) Exclusion criterion : High blood pressure Other significant disease Use certain medication ( decided investigator )</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>COPD</keyword>
	<keyword>prednisolone</keyword>
	<keyword>bone biopsy</keyword>
	<keyword>tetracycline labelling</keyword>
</DOC>